Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Dobson

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Journal of Neurology|September 7, 2023
Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case-control study in an English population-based cohortBenjamin M Jacobs, Pooja Tank, Jonathan P Bestwick, et al.
JAMA Neurology|December 27, 2022
Association Between Antiepileptic Drugs and Incident Parkinson DiseaseDaniel Belete, Benjamin M Jacobs, Cristina Simonet, et al.
Nature Reviews. Neurology|November 27, 2025
Towards primary prevention of multiple sclerosisRuth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.
Journal of Alzheimer'S Disease : JAD|March 29, 2021
The Influence of Socioeconomic Deprivation on Dementia Mortality, Age at Death, and Quality of Diagnosis: A Nationwide Death Records Study in England and Wales 2001-2017Mark Jitlal, Guru N K Amirthalingam, Tasvee Karania, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosisRuth Dobson, David Holden, Nicola Vickaryous, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderMoneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Journal of Neuroimmunology|February 23, 2010
Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosisRuth Dobson, R F Miller, H E Palmer, et al.
Journal of Neurology|July 15, 2025
Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysisBruno Kusznir Vitturi, Maria Cellerino, Daniele Boccia, et al.
European Journal of Neurology|October 28, 2025
Childhood and Adolescent Environmental Risk Factors for Multiple Sclerosis: A Systematic Review With Meta-AnalysisBruno Kusznir Vitturi, Maria Cellerino, Daniele Boccia, et al.
International Journal of MS Care|July 9, 2024
The Impact of COVID-19 on the Employment of People With Multiple Sclerosis: A Multiple Methods StudyBlanca De Dios Perez, Charlotte Pritchard, Katie Powers, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Journal of Neurology|September 7, 2023
Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case-control study in an English population-based cohortBenjamin M Jacobs, Pooja Tank, Jonathan P Bestwick, et al.
JAMA Neurology|December 27, 2022
Association Between Antiepileptic Drugs and Incident Parkinson DiseaseDaniel Belete, Benjamin M Jacobs, Cristina Simonet, et al.
Nature Reviews. Neurology|November 27, 2025
Towards primary prevention of multiple sclerosisRuth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.
Journal of Alzheimer'S Disease : JAD|March 29, 2021
The Influence of Socioeconomic Deprivation on Dementia Mortality, Age at Death, and Quality of Diagnosis: A Nationwide Death Records Study in England and Wales 2001-2017Mark Jitlal, Guru N K Amirthalingam, Tasvee Karania, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosisRuth Dobson, David Holden, Nicola Vickaryous, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderMoneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Journal of Neuroimmunology|February 23, 2010
Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosisRuth Dobson, R F Miller, H E Palmer, et al.
Journal of Neurology|July 15, 2025
Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysisBruno Kusznir Vitturi, Maria Cellerino, Daniele Boccia, et al.
European Journal of Neurology|October 28, 2025
Childhood and Adolescent Environmental Risk Factors for Multiple Sclerosis: A Systematic Review With Meta-AnalysisBruno Kusznir Vitturi, Maria Cellerino, Daniele Boccia, et al.
International Journal of MS Care|July 9, 2024
The Impact of COVID-19 on the Employment of People With Multiple Sclerosis: A Multiple Methods StudyBlanca De Dios Perez, Charlotte Pritchard, Katie Powers, et al.
Pageof 19